Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001021014-04-000003
Filing Date
2004-03-19
Accepted
2004-03-19 19:26:18
Documents
1
Period of Report
2004-03-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5236
  Complete submission text file 0001021014-04-000003.txt   7256
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Issuer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 175 CROSSING BOULEVARD FRAMINGHAM MA 01702
Business Address C/O GTC BIOTHERAPEUTICS, INC. 175 CROSSING BOULEVARD FRAMINGHAM MA 01702 5083705261
COX GEOFFREY F (Reporting) CIK: 0001021014 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-21794 | Film No.: 04681076
SIC: 2836 Biological Products, (No Diagnostic Substances)